This represents the primary web site in Texas; Medical Metropolis Frisco to leverage the advantages of HOLO Portal, the world’s first synthetic intelligence (AI)-driven, augmented actuality (AR) system for spine surgical procedure.
DEERFIELD, Sick., March 02, 2023 (GLOBE NEWSWIRE) — Surgalign Holdings, Inc. (Nasdaq: SRGA), a worldwide medical expertise firm centered on elevating the usual of care by driving the evolution of digital surgical procedure, at the moment introduced that Medical Metropolis Frisco, a world-class acute care hospital in Frisco, TX and a part of HCA Healthcare, is the most recent medical facility to clinically use its HOLO Portal Surgical Navigation System. The final process was carried out by Dr. Ripul Panchal, DO, a board-certified, fellowship-trained neurosurgeon with experience within the administration of spinal issues.
Terry Wealthy, President and CEO of Surgalign commented, “I want to congratulate Dr. Panchal and his workforce for being the primary adopters of HOLO Portal in Texas and for his or her ongoing dedication to enhancing affected person outcomes, a imaginative and prescient we share at Surgalign. Since HOLO Portal was launched, over 30 instances have been carried out. Whereas the gross sales course of has confirmed to be longer than anticipated, our pipeline continues to develop, and we now have gathered insights from the medical neighborhood which is able to in flip, enhance system performance. We have now system enhancements coming quickly, with extra purposes in growth for each HOLO Portal and our HOLO AI Platform, which is able to strengthen our expertise and worth proposition to our prospects additional.”
Dr. Panchal added, “I used to be an early adopter of augmented actuality expertise within the OR and am happy to be transferring to the subsequent technology expertise provided by HOLO Portal. Its distinctive holographic show is extra comfy to make use of than typical AR headsets, whereas the built-in AI enhances each the picture high quality and workflow.” Dr. Panchal is a board licensed, fellowship-trained neurosurgeon with experience in administration of spinal issues. He served as Director of the Backbone Fellowship Program and as Assistant Professor within the Division of Neurological Surgical procedure at College of California, Davis College of Medication for 5 years. He focuses on neurological surgical procedure and spine surgical procedure and is affiliated with Medical Metropolis McKinney, Medical Metropolis Frisco, and Sarah Cannon Most cancers Institute. He actively practices on the American Neurospine Institute, PLLC in Plano, TX.
Surgalign acquired U.S. Food & Drug Administration (FDA) 510(ok) clearance to be used of the HOLO Portal system inside lumbar spine procedures in January 2022. With FDA clearance, HOLO Portal turned the world’s first surgical steering system to include AI and AR. The HOLO Portal system’s AI processes intraoperative photos to autonomously phase and label the anatomy and plan patient-specific pedicle screw trajectories which are accredited by the surgeon. The system makes use of AR to overlay the segmented AI reconstruction over the affected person’s precise anatomy, offering real-time 3D visualization all through the surgical process, serving to surgeons visualize trajectories, whereas guiding surgical devices. 5 medical amenities have utilized HOLO Portal since Could 2022 and there have been over 30 instances carried out so far.
About Surgalign Holdings, Inc.
Surgalign Holdings, Inc. is a worldwide medical expertise firm dedicated to the promise of digital well being to drive transformation throughout the surgical panorama. Uniquely aligned and resourced to advance the usual of care, the corporate is constructing applied sciences physicians and different well being suppliers will look to for what is really potential for his or her sufferers. Surgalign is concentrated on growing options that predictably ship superior scientific and financial outcomes. Surgalign markets merchandise all through america and in roughly 50 international locations worldwide by an increasing community of high impartial distributors. Surgalign is headquartered in Deerfield, IL, with business, innovation and design facilities in San Diego, CA, Warsaw and Poznan, Poland, and Wurmlingen, Germany. Be taught extra at www.surgalign.com and join on LinkedIn, Twitter and Instagram.
About Medical Metropolis Frisco
Medical Metropolis Frisco, a Medical Metropolis Plano facility, is a 98-bed acute care hospital that gives a broad vary of providers, together with a Degree III Trauma Middle, cardiovascular, neurological, spine, orthopedics, robotic-assisted laparoscopic surgical procedure, Degree III neonatal ICU (NICU), girls’s providers and different specialties. Magnet® acknowledged for nursing excellence, Medical Metropolis Frisco is silver LEED licensed for environmental and vitality effectivity. “A” rated for security by the Leapfrog Group. Medical Metropolis Frisco is a part of Medical Metropolis Healthcare.
Ahead Trying Statements
This press launch incorporates forward-looking statements together with, with out limitation, statements relating the supposed use of proceeds from the registered direct providing. These forward-looking statements are primarily based on administration’s present expectations, estimates and projections about our business, our administration’s beliefs and sure assumptions made by our administration. Phrases resembling “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” variations of such phrases and comparable expressions are supposed to establish such forward-looking statements. Components that would trigger precise outcomes to vary materially from these forward-looking statements embody: i) the Firm’s entry to satisfactory working money move, commerce credit score, borrowed funds and fairness capital to fund its operations and pay its obligations as they grow to be due, and the phrases on which exterior financing could also be accessible, together with the influence of opposed developments or disruption within the international credit score and fairness markets; (ii) dangers referring to present or potential litigation or regulatory actions; (iii) the identification of management deficiencies, together with materials weaknesses in inside management over monetary reporting; (iv) basic worldwide financial circumstances and associated uncertainties; (v) the continued influence of the COVID-19 and the Firm’s makes an attempt at mitigation, notably in worldwide markets served by the Firm; (vi) the failure by the Firm to establish, develop and efficiently implement its strategic initiatives, notably with respect to its digital surgical procedure technique ; (vii) the reliability of our provide chain; (viii) our means to satisfy obligations, together with buy minimums, beneath our vendor and different agreements; (ix) whether or not or when the demand for procedures involving our merchandise will enhance; (x) our monetary place and outcomes, whole income, product income, gross margin, and operations; (xi) failure to understand, or surprising prices in searching for to understand, the anticipated advantages of the Holo Surgical Inc. (“Holo Surgical”) and Inteneural Networks Inc. (“INN”) acquisitions, together with the failure of Holo Surgical’s and INN’s services and products to be satisfactorily developed or obtain relevant regulatory approvals or on account of the failure to commercialize and distribute its merchandise; (xii) the failure to successfully combine Holo Surgical’s and INN’s operations with these of the Firm, together with: retention of key personnel; the impact on relationships with prospects, suppliers, and different third events; and the diversion of administration time and a focus to the mixing; (xiii) the variety of shares and amount of money that will probably be required in reference to any post-closing milestone funds, together with on account of adjustments within the buying and selling worth of the Firm’s widespread inventory and their impact on the amount of money wanted by the Firm to fund any post-closing milestone funds in reference to the acquisitions; (xiv) the continuation of current high quality points with respect to our international provide chain and (xv) the impact and timing of adjustments in legal guidelines or in governmental laws. These components must be thought of rigorously, and undue reliance shouldn’t be positioned on the forward-looking statements. Every forward-looking assertion on this communication speaks solely as of the date of the actual assertion.
These forward-looking statements are usually not ensures of future efficiency and are topic to numerous dangers and uncertainties, together with market and different circumstances and the dangers recognized in Surgalign’s most up-to-date Annual Report on Kind 10-Okay and different filings with the SEC. Our precise outcomes could differ materially from the anticipated outcomes mirrored in these forward-looking statements. Copies of Surgalign’s SEC filings could also be obtained with out cost by visiting Surgalign’s web site at www.surgalign.com or the SEC’s web site at www.sec.gov. We undertake no obligation to replace these forward-looking statements besides as could also be required by regulation.
Investor Relations and Media Relations Contact:
Tel: +1 917 887 8434
Discussion about this post